Department of Cardiac Surgery, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.
Department of Cardiology, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.
Eur J Cardiothorac Surg. 2017 Sep 1;52(3):565-572. doi: 10.1093/ejcts/ezx129.
Management strategy for unbalanced complete atrioventricular septal defects (CASVSDs) includes single-ventricle (SV) palliation and primary or staged biventricular (BiV) repair. More recently, BiV conversion (BiVC) from SV palliation and staged BiV recruitment (BiVR) have also been advocated. This study assesses mid-term outcomes in patients with unbalanced CASVSDs according to management strategy.
Consecutive patients with unbalanced CASVSDs who underwent surgery at a tertiary care centre from January 2000 to February 2016 with institutional review board approval. The index surgery was defined as the first palliation procedure for the SV group, a BiV repair for the BiV repair group and conversion or the first procedure for recruitment for the BiVC/BiVR group. Kaplan-Meier and Cox regression were used for time-to-event analysis of death/transplant and unplanned reinterventions that occurred after the index surgery.
There were 212 patients: 82 (38.7%) had SV palliation, 67 (31.6%) had BiV repair and 63 (29.7%) had BiVC/BiVR, respectively; 50 patients had undergone a successful BiVC. There were 93 (43.9%) boys; 51 (24%) patients had Down syndrome; and 101 (48%) patients had heterotaxy. In the entire cohort, there were 40 (18.9%) deaths, 110 (51.9%) reinterventions, 82 (38.7%) surgical reinterventions and 70 (33%) catheter reinterventions, with some patients having more than 1 reintervention. Median length of follow-up was 35 (range 1-192) months. The BiVC/BiVR group had a transplant-free survival benefit similar to that of the primary BiV repair group compared with the SV group. The BiV repair group needed fewer catheter-based reinterventions compared with the SV and BiVC/BiVR groups.
BiVC or BiVR from an SV pathway can be achieved with low rates of mortality and morbidity in patients with unbalanced CASVSDs.
不平衡完全性房室间隔缺损(CASVSD)的管理策略包括单心室(SV)姑息治疗和原发性或分期双心室(BiV)修复。最近,从 SV 姑息治疗转为双心室(BiVC)和分期双心室招募(BiVR)也得到了提倡。本研究根据管理策略评估了患有不平衡性 CASVSD 患者的中期结果。
回顾性分析了 2000 年 1 月至 2016 年 2 月在一家三级医疗中心接受手术的连续患有不平衡性 CASVSD 的患者,本研究获得了机构审查委员会的批准。索引手术被定义为 SV 组的第一次姑息手术,BiV 修复组的 BiV 修复,以及 BiVC/BiVR 组的转换或第一次招募手术。Kaplan-Meier 和 Cox 回归用于索引手术后发生的死亡/移植和计划外再次介入的时间事件分析。
共有 212 名患者:82 名(38.7%)接受 SV 姑息治疗,67 名(31.6%)接受 BiV 修复,63 名(29.7%)接受 BiVC/BiVR,50 名患者成功进行了 BiVC。93 名(43.9%)为男性;51 名(24%)患者患有唐氏综合征;101 名(48%)患者患有异构症。在整个队列中,有 40 例(18.9%)死亡,110 例(51.9%)再次介入,82 例(38.7%)手术再次介入,70 例(33%)导管再次介入,一些患者有不止一次的再次介入。中位随访时间为 35 个月(范围 1-192 个月)。与 SV 组相比,BiVC/BiVR 组的无移植生存率与原发性 BiV 修复组相似。与 SV 和 BiVC/BiVR 组相比,BiV 修复组需要更少的基于导管的再次介入。
在患有不平衡性 CASVSD 的患者中,从 SV 途径进行 BiVC 或 BiVR 可以实现较低的死亡率和发病率。